Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/58419
Title: Repositioning of the global epicentre of non-optimal cholesterol
Authors: Cristina Taddei
Bin Zhou
Honor Bixby
Rodrigo M. Carrillo-Larco
Goodarz Danaei
Rod T. Jackson
Farshad Farzadfar
Marisa K. Sophiea
Mariachiara Di Cesare
Maria Laura Caminia Iurilli
Andrea Rodriguez Martinez
Golaleh Asghari
Klodian Dhana
Pablo Gulayin
Sujay Kakarmath
Marilina Santero
Trudy Voortman
Leanne M. Riley
Melanie J. Cowan
Stefan Savin
James E. Bennett
Gretchen A. Stevens
Christopher J. Paciorek
Wichai Aekplakorn
Renata Cifkova
Simona Giampaoli
Andre Pascal Kengne
Young Ho Khang
Kari Kuulasmaa
Avula Laxmaiah
Paula Margozzini
Prashant Mathur
Børge G. Nordestgaard
Dong Zhao
Mette Aadahl
Leandra Abarca-Gómez
Hanan Abdul Rahim
Niveen M. Abu-Rmeileh
Benjamin Acosta-Cazares
Robert J. Adams
Imelda A. Agdeppa
Javad Aghazadeh-Attari
Carlos A. Aguilar-Salinas
Charles Agyemang
Tarunveer S. Ahluwalia
Noor Ani Ahmad
Ali Ahmadi
Naser Ahmadi
Soheir H. Ahmed
Wolfgang Ahrens
Kamel Ajlouni
Monira Alarouj
Fadia AlBuhairan
Shahla AlDhukair
Mohamed M. Ali
Abdullah Alkandari
Ala’a Alkerwi
Eman Aly
Deepak N. Amarapurkar
Philippe Amouyel
Lars Bo Andersen
Sigmund A. Anderssen
Ranjit Mohan Anjana
Alireza Ansari-Moghaddam
Hajer Aounallah-Skhiri
Joana Araújo
Inger Ariansen
Tahir Aris
Raphael E. Arku
Nimmathota Arlappa
Krishna K. Aryal
Thor Aspelund
Maria Cecília F. Assunção
Juha Auvinen
Mária Avdicová
Ana Azevedo
Fereidoun Azizi
Mehrdad Azmin
Nagalla Balakrishna
Mohamed Bamoshmoosh
Maciej Banach
Piotr Bandosz
José R. Banegas
Carlo M. Barbagallo
Alberto Barceló
Amina Barkat
Iqbal Bata
Anwar M. Batieha
Assembekov Batyrbek
Louise A. Baur
Robert Beaglehole
Antonisamy Belavendra
Habiba Ben Romdhane
Mikhail Benet
Marianne Benn
Salim Berkinbayev
Antonio Bernabe-Ortiz
Gailute Bernotiene
Heloisa Bettiol
Santosh K. Bhargava
Dasman Diabetes Institute
University of Science and Technology, Yemen
Western Norway University of Applied Sciences
Lietuvos sveikatos mokslų universitetas
Kazakh National Medical University
Université de Lille
Caja Costarricense de Seguro Social
Beijing Anzhen Hospital, Capital Medical University
Qatar University
Birzeit University
Luxembourg Institute of Health
Al Farabi Kazakh National University
Food and Nutrition Research Institute Manila
Universidad Peruana Cayetano Heredia
Haskoli Islands
Jordan University of Science and Technology
Institute for Clinical Effectiveness and Health Policy, Ciudad Autonoma de Buenos Aires
University of Tunis El Manar
National Center for Diabetes, Endocrinology and Genetics Jordan
Harvard T.H. Chan School of Public Health
Erasmus MC
Zahedan University of Medical Sciences
Pontificia Universidad Católica de Chile
South African Medical Research Council
Tehran University of Medical Sciences
Organisation Mondiale de la Santé
Universidad Autónoma de Madrid
The University of Sydney
Indian Council of Medical Research
University of California, Berkeley
Shahid Beheshti University of Medical Sciences, Research Institute for Endocrine Science
Shahrekord University of Medical Sciences
Urmia University of Medical Sciences
Flinders University
Mohammed V University in Rabat
Shahid Beheshti University of Medical Sciences
Rush University Medical Center
Università degli Studi di Palermo
National Institute of Nutrition India
Oulu University Hospital
Charles University
Steno Diabetes Center Copenhagen
Dalhousie University
Copenhagen University Hospital
Imperial College London
Universidade Federal de Pelotas
University of Massachusetts Amherst
Middlesex University
Pan American Health Organization
Seoul National University
Oulun Yliopisto
Kementerian Kesihatan Malaysia
Mahidol University
Gdanski Uniwersytet Medyczny
Norwegian Institute of Public Health
Bombay Hospital and Medical Research Centre
Universitetet i Oslo
Istituto Superiore Di Sanita
Instituto Nacional de la Nutrición Salvador Zubiran
Instituto Mexicano del Seguro Social
University of Bremen
Universidade de Sao Paulo - USP
Universidade do Porto
Frederiksberg Hospital
Medical University of Lodz
University of Auckland
Norges idrettshøgskole
Harvard Medical School
Universiteit van Amsterdam
Christian Medical College, Vellore
Madras Diabetes Research Foundation
Abt Associates
Independent Researcher
Aldara Hospital and Medical Center
Cafam University Foundation
Finnish Institute for Health and Welfare
National Institute of Public Health
King Abdullah International Medical Research Center
Thomayer Hospital
Regional Authority of Public Health
Sunder Lal Jain Hospital
Keywords: Multidisciplinary
Issue Date: 4-Jun-2020
Citation: Nature. Vol.582, No.7810 (2020), 73-77
Abstract: © 2020, The Author(s), under exclusive licence to Springer Nature Limited. High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.
URI: http://repository.li.mahidol.ac.th/dspace/handle/123456789/58419
metadata.dc.identifier.url: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085994877&origin=inward
ISSN: 14764687
00280836
Appears in Collections:Scopus 2020

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.